Discontinuation report HUMATROPE
Report ID | 106800 |
Drug Identification Number | 00745626 |
Brand name | HUMATROPE |
Common or Proper name | Somatropin for injection |
Company Name | ELI LILLY CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SOMATROPIN |
Strength(s) | 1MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 5 mg vial |
ATC code | H01AC |
ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-01-15 |
Actual discontinuation date | 2021-01-15 |
Remaining supply date | 2021-01-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-01-18 | French | Compare |
v7 | 2021-01-18 | English | Compare |
v6 | 2020-05-11 | French | Compare |
v5 | 2020-05-11 | English | Compare |
v4 | 2020-02-20 | French | Compare |
v3 | 2020-02-20 | English | Compare |
v2 | 2020-02-20 | French | Compare |
v1 | 2020-02-20 | English | Compare |
Showing 1 to 8 of 8